Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind RCT to Evaluate the Effect of Botulinum Toxin in Raynaud Phenomenon

NCT05125029 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT05125029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05125029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind RCT to Evaluate the Effect of Botulinum Toxin in Raynaud Phenomenon
Lead sponsor
Emory University
Phase
Phase 4
Overall status
Completed
Start date
February 10, 2022
Completion date
May 15, 2025
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

raynaud phenomenon